P

Inventor

XU GUOZHANG

US31 patents
⚠️ This page may combine multiple inventors who share the name “XU GUOZHANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

21 patents
US8013153B2Sep 6, 2011

Substituted pyrimidine kinase inhibitors

JANSSEN PHARMACEUTICA NV14 citations76
US10214493B2Feb 26, 2019

Indazole derivatives useful as glucagon receptor antagonists

JANSSEN PHARMACEUTICA NV3 citations72
US10000473B2Jun 19, 2018

Indazole derivatives useful as glucagon receptor antagonists

JANSSEN PHARMACEUTICA NV3 citations72
US11098016B2Aug 24, 2021

Indazole derivatives useful as glucagon receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations62
US11014917B2May 25, 2021

5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators

JANSSEN PHARMACEUTICA NV0 citations62
US12545677B2Feb 10, 2026

Compounds useful as factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations61
US7846953B2Dec 7, 2010

Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulators

JANSSEN PHARMACEUTICA NV3 citations59
US12286429B2Apr 29, 2025

5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations52
US11958856B2Apr 16, 2024

Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations51
US10774048B2Sep 15, 2020

Indazole derivatives useful as glucagon receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations51
US10696662B2Jun 30, 2020

5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators

JANSSEN PHARMACEUTICA NV0 citations51
US9012412B2Apr 21, 2015

Dual SGLT1/SGLT2 inhibitors

JANSSEN PHARMACEUTICA NV0 citations51
US11897880B2Feb 13, 2024

7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11845748B2Dec 19, 2023

Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11919881B2Mar 5, 2024

Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations49
US11814364B2Nov 14, 2023

Pyridine N-oxide derivatives useful as factor XIa inhibitors

JANSSEN PHARMACEUTICA NV0 citations48
US8344009B2Jan 1, 2013

Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators

JANSSEN PHARMACEUTICA NV1 citations48
US7825244B2Nov 2, 2010

Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis

JANSSEN PHARMACEUTICA NV1 citations47
US10251864B2Apr 9, 2019

Indole derivatives useful as glucagon receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations40
US7893064B2Feb 22, 2011

Hydrazone derivatives as kinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations40
US10815210B2Oct 27, 2020

Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators

JANSSEN PHARMACEUTICA NV0 citations39

BIGNAN GILLES

5 patents

CHAKRAVARTY DEVRAJ

2 patents

XU GUOZHANG

1 patent

JOHNSON & JOHNSON PHARM RES

1 patent

BAINDUR NAND

1 patent